Company Profile - JSP PHARMACEUTICAL MANUFACTURING (THAILAND) PUBLIC COMPANY LIMITED สำนักงานคณะกรรมการกำกับหลักทรัพย์และตลาดหลักทรัพย์ Printed on 09 August 2024 20:12 Company Profile JSP
firms and the audit work quality of listed companies.Senior Assistant Secretary-General Prakid Punyashthiti said: ?The overall results of the second-cycle inspection show continued improvement in the work
176.18 million (increasing 21.57%). The total revenue from overseas subsidiaries in year 2018 increased THB 11.99 million mainly from the establishment of the manufacturing factory in Vietnam, resulting in
Q3/2018 increased THB 10.81 million in the nine-month period in Q3/2018 compared to previous year mainly from the establishment of the manufacturing factory in Vietnam, resulting in the 41.74% increase
solution and other medical product manufacturing and trading business. Previously the company held 44% of all shares. Later in February 2018, the company acquired additional shares from one of the
sectors. Tourism was heavily affected by airspace and border closures, while merchandise exports fell sharply as demand from major trading partners fell, impacting both manufacturing production and domestic
consist of THB 3,022 million as the cost of construction, show equipment, theme park design and decoration, service fee for specialist and interest expense, while the remaining THB 548 million accounts for
ที่ กบร No. Kor Bor Ror. 032/2017 November 9, 2017 President The Stock Exchange of Thailand Re : Increase of the investment proportion in the ordinary shares of Pattaya Manufacturing Co., Ltd. Dear
% shareholding of its registered capital held by the Company. The total investment cost of THB 3,570 million consist of THB 3,022 million as the cost of construction, show equipment, theme park design and